fda compounding semaglutide warning letters news issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Last month, the FDA issued

These aggregates reduce the amount of active, available semaglutide in solution

On July 3, 2024, a concerning study published by researchers from Mass Eye and Ear found that patients taking semaglutide, the active ingredient in drugs like Ozempic and Wegovy, may be at a higher risk of developing a rare blinding condition known as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Your body needs time to adapt to each dose level before taking on additional receptor activation

Then, the researchers administered exendin-4 via intrathecal injection to the experimental rats and observed a reduction in pain sensitivity, alleviation of neural inflammation, and suppression of inflammatory factors such as IL-1, TNF-, and iNOS

PMID: 30575104

U.S.-based Eli Lilly also makes the current bestselling weight-loss drug, Zepbound, which is called Mounjaro when patients take it to fight diabetes